Hagen, Germany

Britta Vallazza

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Beckman Research Institute, City of Hope, Biontech Se, Tron—translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Ggmbh. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Britta Vallazza. Retrieved from https://idiyas.com/inventor/britta-vallazza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 77.8

 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Hagen, DE (2015 - 2020)
  • Darmstadt, DE (2022 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Britta Vallazza: Pioneering Advancements in RNA Stabilization

Introduction

Britta Vallazza, an innovative inventor based in Hagen, Germany, has made significant contributions to the field of nucleic acids and RNA stabilization. With a portfolio of eight patents, her work focuses on enhancing the stability and efficiency of RNA molecules, which is crucial for various applications in biotechnology and medicine.

Latest Patents

Among her latest patents is the invention titled "Stabilization of poly(A) sequence encoding DNA sequences." This invention relates to nucleic acid molecules that contain poly(dA:dT) regions, stabilized through unique methods that enhance their propagation and utilization in obtaining RNA, peptides, or proteins. Notably, the poly(dA:dT) regions include at least one disruption by a sequence that does not solely encode A residues. Another key patent is "3'-UTR sequences for stabilization of RNA," which describes a process for stabilizing RNA, particularly mRNA, thereby improving translation efficiency through modifications in the 3'-untranslated region (UTR) of RNA molecules.

Career Highlights

Throughout her career, Britta Vallazza has been associated with prominent organizations, including City of Hope and the Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz. Her academic and research background has equipped her with the necessary skills to innovate within her field.

Collaborations

Vallazza has collaborated with notable researchers, including John J. Rossi and Ugur Sahin. These partnerships have contributed to her innovative projects and have enabled her to advance her research to new heights.

Conclusion

Britta Vallazza exemplifies the spirit of innovation in biotechnology, with her patents and research paving the way for advancements in RNA technology. Her contributions are vital in understanding and developing applications that utilize RNA stabilization, promising a significant impact in medical and scientific fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…